Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...

Jaypirca is a targeted therapy for CLL and other specific cancers. It is known as a Bruton’s tyrosine kinase inhibitor (BTK inhibitor). BTK is an enzyme that helps certain types of cancer cells ...

Acute myelogenous leukemia (AML) is more common in adults than children and is more likely to affect males than females. Overall, however, it is rare. Chronic myelogenous leukemia (CML ...

Imatinib, a tyrosine kinase inhibitor of Bcr-Abl, is the current first-line therapy for patients with chronic myelogenous leukemia (CML). Despite the effectiveness of imatinib, many patients ...